Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • COVID-19
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • Topics A-Z
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

May 26, 2015; 84 (21) Patient Page

Cost of disease-modifying therapies for multiple sclerosisAbout multiple sclerosis

Murray G. Brown
First published May 25, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001676
Murray G. Brown
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Cost of disease-modifying therapies for multiple sclerosisAbout multiple sclerosis
Murray G. Brown
Neurology May 2015, 84 (21) e181-e185; DOI: 10.1212/WNL.0000000000001676

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
727

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Article Information

vol. 84 no. 21 e181-e185
DOI: 
https://doi.org/10.1212/WNL.0000000000001676
PubMed: 
26009567

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published May 25, 2015.

Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Murray G. Brown, PhD
  1. Murray G. Brown, PhD
  2. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. NONE

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. NONE

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

View Full Text

Article usage

Article usage: May 2015 to April 2022

AbstractFullPdfSource
May 20153438978Highwire
Jun 201515310992Highwire
Jul 20151216940Highwire
Aug 2015695524Highwire
Sep 2015694914Highwire
Oct 2015465018Highwire
Nov 2015222715Highwire
Dec 2015433610Highwire
Jan 2016393617Highwire
Feb 2016422317Highwire
Mar 2016464612Highwire
Apr 201622167Highwire
May 201621136Highwire
Jun 201633186Highwire
Jul 20161176Highwire
Aug 201619156Highwire
Sep 20161465Highwire
Oct 201614413Highwire
Nov 20161269Highwire
Dec 201613104Highwire
Jan 20171374Highwire
Feb 2017942Highwire
Mar 201711105Highwire
Apr 201712112Highwire
May 20171182Highwire
Jun 20174123Highwire
Jul 2017862Highwire
Aug 201729513Highwire
Sep 2017522Highwire
Oct 2017216Highwire
Nov 2017974Highwire
Dec 2017081Highwire
Jan 20180144Highwire
Feb 20180141Highwire
Mar 20180232Highwire
Apr 20180252Highwire
May 20180333Highwire
Jun 20180351Highwire
Jul 20180454Highwire
Aug 20180170Highwire
Sep 20180434Highwire
Oct 20180392Highwire
Nov 20182346Highwire
Dec 20180172Highwire
Jan 20190184Highwire
Feb 20191163Highwire
Mar 20190156Highwire
Apr 20190135Highwire
May 20191125Highwire
Jun 20190112Highwire
Jul 20191147Highwire
Aug 20190143Highwire
Sep 20190117Highwire
Oct 20191131Highwire
Nov 201912612Highwire
Dec 20190523Highwire
Jan 20200316Highwire
Feb 20200164Highwire
Mar 20201195Highwire
Apr 20200195Highwire
May 20201173Highwire
Jun 2020160Highwire
Jul 20200221Highwire
Aug 20200132Highwire
Sep 20200162Highwire
Oct 20200216Highwire
Nov 20201135Highwire
Dec 20202192Highwire
Jan 20210171Highwire
Feb 2021086Highwire
Mar 20210263Highwire
Apr 20211251Highwire
May 20210294Highwire
Jun 20211220Highwire
Jul 20210228Highwire
Aug 202122110Highwire
Sep 20211197Highwire
Oct 202151626Highwire
Nov 20211826Highwire
Dec 20210165Highwire
Jan 20220514Highwire
Feb 202201617Highwire
Mar 20221920Highwire
Apr 20221114Highwire

Cited By...

  • 7 Citations
  • Google Scholar

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • WHAT ARE MS “DISEASE-MODIFYING THERAPIES”?
    • WHAT DID THE AUTHORS STUDY?
    • WHAT DID THE AUTHORS FIND?
    • WHAT IS STILL UNKNOWN?
    • WHY IS THE STUDY OF DMT PRICE INCREASES IMPORTANT?
    • WHAT IS THE MARKET COMPETITION?
    • COST-EFFECTIVENESS REVISITED
    • A NATIONAL CONVERSATION
    • REFERENCES
    • WHAT IS MULTIPLE SCLEROSIS?
    • HOW MS AFFECTS THE BRAIN
    • FOR MORE INFORMATION
  • Figures & Data
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

  • All Demyelinating disease (CNS)
  • Multiple sclerosis

Alert Me

  • Alert me when eletters are published
Neurology: 98 (21)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise